These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 8370162

  • 1. A longitudinal study of the IgG antibody response to HIV-1 p17 gag protein in HIV-1+ patients with haemophilia: titre and avidity.
    Chargelegue D, O'Toole CM, Colvin BT.
    Clin Exp Immunol; 1993 Sep; 93(3):331-6. PubMed ID: 8370162
    [Abstract] [Full Text] [Related]

  • 2. A 7-year analysis of anti-Gag (p17 and p24) antibodies in HIV-1-seropositive patients with haemophilia: immunoglobulin G titre and avidity are early predictors of clinical course.
    Chargelegue D, Colvin BT, O'Toole CM.
    AIDS; 1993 Nov; 7 Suppl 2():S87-90. PubMed ID: 7909231
    [Abstract] [Full Text] [Related]

  • 3. Differential maturation of avidity of IgG antibodies to gp41, p24 and p17 following infection with HIV-1.
    Thomas HI, Wilson S, O'Toole CM, Lister CM, Saeed AM, Watkins RP, Morgan-Capner P.
    Clin Exp Immunol; 1996 Feb; 103(2):185-91. PubMed ID: 8565298
    [Abstract] [Full Text] [Related]

  • 4. The affinity of IgG antibodies to gag p24 and p17 in HIV-1-infected patients correlates with disease progression.
    Chargelegue D, Stanley CM, O'Toole CM, Colvin BT, Steward MW.
    Clin Exp Immunol; 1995 Feb; 99(2):175-81. PubMed ID: 7851008
    [Abstract] [Full Text] [Related]

  • 5. Earlier detection of human immunodeficiency virus type 1 p24 antigen and immunoglobulin G and M antibodies to p17 antigen in seroconversion serum panels by immune complex transfer enzyme immunoassays.
    Hashida S, Ishikawa S, Hashinaka K, Nishikata I, Oka S, Ishikawa E.
    Clin Diagn Lab Immunol; 2000 Nov; 7(6):872-81. PubMed ID: 11063490
    [Abstract] [Full Text] [Related]

  • 6. Decline in CTL and antibody responses to HIV-1 p17 and p24 antigens in HIV-1-infected hemophiliacs irrespective of disease progression. A 5-year follow-up study.
    O'Toole CM, Lowdell MW, Chargelegue D, Colvin BT.
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1361-8. PubMed ID: 1281655
    [Abstract] [Full Text] [Related]

  • 7. Optimal conditions of immune complex transfer enzyme immunoassays for antibody IgGs to HIV-1 using recombinant p17, p24, and reverse transcriptase as antigens.
    Hashida S, Ishikawa S, Hashinaka K, Nishikata I, Oka S, Shimada K, Saito A, Takamizawa A, Shinagawa H, Ishikawa E.
    J Clin Lab Anal; 1998 Aug; 12(2):98-107. PubMed ID: 9524294
    [Abstract] [Full Text] [Related]

  • 8. Prevalence and persistence of antibody titers to recombinant HIV-1 core and matrix proteins in HIV-1 infection.
    Janvier B, Mallet F, Cheynet V, Dalbon P, Vernet G, Besnier JM, Choutet P, Goudeau A, Mandrand B, Barin F.
    J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):898-903. PubMed ID: 8315575
    [Abstract] [Full Text] [Related]

  • 9. Relation between humoral responses to HIV gag and env proteins at seroconversion and clinical outcome of HIV infection.
    Cheingsong-Popov R, Panagiotidi C, Bowcock S, Aronstam A, Wadsworth J, Weber J.
    BMJ; 1991 Jan 05; 302(6767):23-6. PubMed ID: 1899349
    [Abstract] [Full Text] [Related]

  • 10. Immunization of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses.
    Martin SJ, Vyakarnam A, Cheingsong-Popov R, Callow D, Jones KL, Senior JM, Adams SE, Kingsman AJ, Matear P, Gotch FM.
    AIDS; 1993 Oct 05; 7(10):1315-23. PubMed ID: 8267904
    [Abstract] [Full Text] [Related]

  • 11. More reliable diagnosis of infection with human immunodeficiency virus type 1 (HIV-1) by detection of antibody IgGs to pol and gag proteins of HIV-1 and p24 antigen of HIV-1 in urine, saliva, and/or serum with highly sensitive and specific enzyme immunoassay (immune complex transfer enzyme immunoassay): a review.
    Hashida S, Hashinaka K, Ishikawa S, Ishikawa E.
    J Clin Lab Anal; 1997 Oct 05; 11(5):267-86. PubMed ID: 9292394
    [Abstract] [Full Text] [Related]

  • 12. Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities.
    Koup RA, Pikora CA, Luzuriaga K, Brettler DB, Day ES, Mazzara GP, Sullivan JL.
    J Exp Med; 1991 Dec 01; 174(6):1593-600. PubMed ID: 1744586
    [Abstract] [Full Text] [Related]

  • 13. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
    Lottersberger J, Salvetti JL, Beltramini LM, Tonarelli G.
    Rev Argent Microbiol; 2004 Dec 01; 36(4):151-7. PubMed ID: 15786866
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The absence of loss of antibodies of high affinity to human immunodeficiency virus (HIV) is associated with disease progression in HIV-1-infected patients.
    Chargelegue D, Stanley CM, O'Toole CM, Colvin BT, Steward MW.
    J Infect Dis; 1995 Sep 01; 172(3):897-8. PubMed ID: 7658093
    [No Abstract] [Full Text] [Related]

  • 17. Prevalence of antibodies to the core protein P17, a serological marker during HIV-1 infection.
    Mehta SU, Rupprecht KR, Hunt JC, Kramer DE, McRae BJ, Allen RG, Dawson GJ, Devare SG.
    AIDS Res Hum Retroviruses; 1990 Apr 01; 6(4):443-54. PubMed ID: 1692727
    [Abstract] [Full Text] [Related]

  • 18. Long-term follow-up: no effect of therapeutic vaccination with HIV-1 p17/p24:Ty virus-like particles on HIV-1 disease progression.
    Lindenburg CE, Stolte I, Langendam MW, Miedema F, Williams IG, Colebunders R, Weber JN, Fisher M, Coutinho RA.
    Vaccine; 2002 May 22; 20(17-18):2343-7. PubMed ID: 12009290
    [Abstract] [Full Text] [Related]

  • 19. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D, Bolesta E, Naito T, Gzyl J, Kaneko Y, Kozbor D.
    J Hum Virol; 2001 May 22; 4(6):306-16. PubMed ID: 12082397
    [Abstract] [Full Text] [Related]

  • 20. A prospective study on correlation between the decrease in anti-P17 antibody level and progression to AIDS in asymptomatic carriers of HIV.
    Choudhury AM, Yamada O, Wakamiya N, Kurimura T.
    Microbiol Immunol; 1992 May 22; 36(8):833-40. PubMed ID: 1474934
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.